The Ludwig Boltzmann Institute Applied Diagnostics (lbi:ad) is a translational research institution of the Ludwig Boltzmann Gesellschaft which is combining a team of transdisciplinary scientists, academic and industrial partners from several countries. It follows a new dual biomarker concept for tumor diagnosis. The focus of the institute lies on the development of non-invasive diagnostic methods combining molecular epigenetic and genetic signatures with molecular imaging biomarkers for PET and SPECT analysis. The combination of these two methods will allow for improved functional, spatial and temporal assessment of tumor load and molecular tumor characterization.

Johannes Längle - Forschungsförderungen 2017 - „Fellinger Krebsforschung“
Johannes Längle - Forschungsförderungen - „Fellinger Krebsforschung“

Johannes Längle von der Klinischen Abteilung für Allgemeinchirurgie der
13th YSA PhD Symposium

This year’s PhD Symposium of the Young Scientist Association (YSA) took place on the 8th and 9th of June at the Medical University of Vienna. We are very proud to announce that the poster "Identification
The opening celebration of LBI:AD "Gründer Symposium"
With a quite big team of already 14 employees, the LBI Applied Diagnostics decided to be ready to celebrate its inauguration on the 2nd of May 2017. For this occasion,

Share This: